Tag: ALS
-
Gnome Sciences Unveils Promising ALS Results From Cancer Drug Study
Groundbreaking ALS Findings from a Cancer Drug Study Gnome Sciences, a leader in molecular pathology and translational research, announced a significant advance in the fight against amyotrophic lateral sclerosis (ALS). In a newly published study, researchers revealed that a cancer drug—originally developed to target tumor growth—demonstrated measurable neuroprotective effects in ALS models. The findings, produced…
-
ALS Breakthrough: Cancer Drug Shows Promise, Gnome Sciences Reports
Gnome Sciences Announces Promising ALS Research Gnome Sciences, a leader in molecular pathology and translational research, has announced encouraging results from a newly published study investigating the potential of a cancer drug in treating amyotrophic lateral sclerosis (ALS). The announcement, made in Columbus, Ohio, underscores a growing interest in repurposing oncology therapies to address complex…
-
Gnome Sciences Announces Cancer Drug Shows Promise for ALS Therapy in New Study
Breakthrough in ALS Research: A Cancer Drug Shows Promise In a notable advance for neurodegenerative disease research, Gnome Sciences, a leader in molecular pathology and translational studies, reports that a cancer drug demonstrates promising effects in models of amyotrophic lateral sclerosis (ALS). The company announced the findings following a newly published study that suggests the…
-
New drug M102 could slow progression of motor neurone disease, say scientists
Promising MND breakthrough centers on M102 A new drug, tentatively named M102, is generating cautious optimism among researchers and patient advocates after preclinical studies suggested it could substantially slow the progression of motor neurone disease (MND). While early results are not a guarantee of clinical success, the development signals a potential shift in how MND…
-
Lewis Moody reveals motor neurone disease diagnosis: rugby icon faces MND with courage
Former England captain Lewis Moody announces MND diagnosis Former England rugby captain Lewis Moody has publicly revealed he has been diagnosed with motor neurone disease (MND), also known as ALS. The 47-year-old, celebrated for his role in England’s 2003 Rugby World Cup triumph with Leicester Tigers, shared the news on social media, describing the diagnosis…
-
Lewis Moody reveals ALS diagnosis: Rugby World Cup winner faces motor neurone disease with resolve
Former England captain Lewis Moody announces ALS diagnosis Former England rugby captain Lewis Moody has revealed that he has been diagnosed with motor neurone disease (ALS). The 47-year-old, who helped England secure the 2003 Rugby World Cup and enjoyed a storied club career with Leicester Tigers, disclosed the news on X, emphasizing that he plans…
-
Lewis Moody Diagnosed With Motor Neurone Disease: Rugby World Cup Legend Faces ALS Battle
Former England captain Lewis Moody reveals motor neurone disease diagnosis Former England rugby captain Lewis Moody has disclosed a diagnosis of motor neurone disease (MND), also known as amyotrophic lateral sclerosis (ALS). The 47-year-old, renowned for his role in England’s 2003 Rugby World Cup triumph and a long, successful career with Leicester Tigers, announced the…
-
Device Identifies Bacteria in Real Time Arrives in Viseu
Real-time bacterial identification device to be unveiled in Viseu A new device designed to identify bacteria in humans, animals, or the environment in real time and to indicate the most effective antibiotic will be presented on Friday in Viseu. Developed by ALS as part of the SMARTgNOTICS consortium—which unites public and private Portuguese entities—the technology…
-
Real-time Bacteria Identification Device Debuts in Viseu
Overview: a new real-time bacterial detector coming to Portugal A groundbreaking device that can identify bacteria in humans, animals, and the surrounding environment in real time and indicate the most effective antibiotic is set to be unveiled in Viseu this Friday. The technology, developed by ALS as part of the SMARTgNOTICS consortium—a collaboration of Portuguese…